KATHLEEN ARCHER: Open Payments
NPI 1861482762 · GRETNA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,937 in 125 payments from 28 companies in 2025. Trend: 2023 $1,632 · 2024 $1,978 · 2025 $1,937
Food & beverage: $1,852Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $318 |
| Amgen Inc. | 13 | $241 |
| AstraZeneca Pharmaceuticals LP | 6 | $172 |
| Lilly USA, LLC | 15 | $167 |
| Axsome Therapeutics, Inc. | 16 | $151 |
| Mannkind Corporation | 3 | $115 |
| Aimmune Therapeutics, Inc. | 3 | $60 |
| PFIZER INC. | 3 | $56 |
| SANOFI-AVENTIS U.S. LLC | 3 | $51 |
| Antares Pharma, Inc. | 3 | $49 |
Products named: VRAYLAR, REPATHA, Auvelity, AFREZZA, KISUNLA, OTEZLA, REXULTI, ZENPEP.
Industry payments across NE — which companies pay providers there.
